Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimal dexmedetomidine + propofol dosing for opioid-free anesthesia induction
ChiCTR2400089952Phase 4Not yet recruiting
- Sponsor
- Zhongshan Hospital, Fudan University
- Start
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of dexmedetomidine and propofol (3 arms), sponsored by Zhongshan Hospital, Fudan University. Primary endpoint: Positive reaction during opioid-free anesthesia induction. Planned start Sep 2024; status: not yet recruiting.
02
Drugs
dexmedetomidinepropofol
Beyond the preview
Go deeper on ChiCTR2400089952.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400089952.